(S (SBAR (IN While) (S (NP (NP (NN image) (NN analysis)) (PP (IN of) (NP (NP (NN chest) (VBN computed) (NN tomography)) (PRN (-LRB- -LRB-) (NP (NNP CT)) (-RRB- -RRB-)))) (PP (IN for) (NP (NNP COVID-19) (NN diagnosis)))) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB intensively)) (VBN studied)))))) (, ,) (NP (JJ little) (NN work)) (VP (VBZ has) (VP (VBN been) (VP (VBN performed) (PP (IN for) (NP (JJ image-based) (JJ patient) (NN outcome) (NN prediction)))))) (. .))
(S (NP (NP (NN Management)) (PP (IN of) (NP (JJ high-risk) (NNS patients))) (PP (IN with) (NP (JJ early) (NN intervention)))) (VP (VBZ is) (NP (NP (DT a) (NN key)) (S (VP (TO to) (VP (VB lower) (NP (NP (DT the) (NN fatality) (NN rate)) (PP (IN of) (NP (NNP COVID-19) (NN pneumonia)))))))) (, ,) (SBAR (IN as) (S (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (NNS patients)))) (VP (VB recover) (ADVP (RB naturally)))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (NP (DT an) (JJ accurate) (NN prediction)) (PP (IN of) (NP (NN disease) (NN progression))) (PP (IN with) (NP (NP (NN baseline) (NN imaging)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (DT the) (JJ initial) (NN presentation)))))))) (VP (MD can) (VP (VB help) (PP (IN in) (NP (JJ patient) (NN management))))) (. .))
(S (PP (IN In) (NP (NP (NN lieu)) (PP (IN of) (NP (NP (JJ only) (NN size) (CC and) (NN volume) (NN information)) (PP (IN of) (NP (JJ pulmonary) (NNS abnormalities) (CC and) (NNS features))) (PP (IN through) (NP (ADJP (JJ deep) (NN learning) (VBN based)) (NN image) (NN segmentation))))))) (, ,) (ADVP (RB here)) (NP (PRP we)) (VP (VBP combine) (NP (NP (NNS radiomics)) (PP (IN of) (NP (NP (NN lung) (NNS opacities)) (CC and) (NP (JJ non-imaging) (NNS features))))) (PP (IN from) (NP (NP (JJ demographic) (NNS data)) (, ,) (NP (JJ vital) (NNS signs)) (, ,) (CC and) (NP (JJ laboratory) (NNS findings)))) (S (VP (TO to) (VP (VB predict) (NP (NP (NN need)) (PP (IN for) (NP (NP (JJ intensive) (NN care) (NN unit)) (PRN (-LRB- -LRB-) (NNP ICU) (-RRB- -RRB-)) (NN admission)))))))) (. .))
(S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN study)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (NP (JJ holistic) (NN information)) (PP (IN of) (NP (DT a) (NN patient))) (PP (VBG including) (NP (UCP (DT both) (NN imaging) (CC and) (JJ non-imaging)) (NNS data)))) (PP (IN for) (NP (NN outcome) (NN prediction)))))))) (. .))
(S (NP (DT The) (VBN proposed) (NNS methods)) (VP (VBD were) (VP (ADVP (RB thoroughly)) (VBN evaluated) (PP (IN on) (NP (NP (NNS datasets)) (VP (ADVP (RB separately)) (VBN collected) (PP (IN from) (NP (NP (CD three) (NNS hospitals)) (, ,) (NP (NP (NP (CD one)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))) (, ,) (NP (NP (CD one)) (PP (IN in) (NP (NNP Iran)))) (, ,) (CC and) (NP (NP (DT another)) (PP (IN in) (NP (NNP Italy))))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ total) (CD 295) (NNS patients)) (PP (IN with) (NP (ADJP (JJ reverse) (NN transcription) (NN polymerase) (NN chain) (NN reaction) (PRN (PRN (-LRB- -LRB-) (NNP RT-PCR) (-RRB- -RRB-)) (VBP assay)) (JJ positive)) (NNP COVID-19) (NN pneumonia)))))))))))) (. .))
(S (NP (PRP$ Our) (JJ experimental) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (S (VP (VBG adding) (NP (JJ non-imaging) (NNS features)))) (VP (MD can) (VP (ADVP (RB significantly)) (VB improve) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN prediction)))) (S (VP (TO to) (VP (VB achieve) (NP (NP (NP (NP (NNP AUC)) (ADVP (RB up) (PP (TO to) (NP (CD 0.884))))) (CC and) (NP (NP (NN sensitivity)) (ADJP (ADJP (RB as) (JJ high)) (PP (IN as) (NP (CD 96.1) (NN %)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (ADJP (JJ valuable) (S (VP (TO to) (VP (VB provide) (NP (JJ clinical) (NN decision) (NN support)) (PP (IN in) (S (VP (VBG managing) (NP (JJ COVID-19) (NNS patients)))))))))))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS methods)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN applied) (PP (TO to) (NP (NP (JJ other) (NN lung) (NNS diseases)) (PP (PP (VBG including)) (SINV (CC but) (RB not) (JJ limited) (PP (PP (TO to)) (NP (ADJP (NN community) (VBN acquired)) (NN pneumonia)))))))))) (. .))
